Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody. - Weaver, Jessica D.; Stack, Edward C.; Buggé, Joshua A.; Changyun Hu; McGrath, Lara; Mueller, Amy; Wong, Masie; Klebanov, Boris; Rahman, Tanzila; Kaufman, Rosemary; Fregeau, Christine; Spaulding, Vikki; et al. (OncoImmunology, 2022)